MedTrace Logo

Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm

NCT04927611 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-09-24

No results posted yet for this study

Summary

The aim of this study is to use single-cell sequencing technology to explore neuroendocrine neoplasm (NEN) molecular biological characteristics, tumor heterogeneity and cell subtypes. Besides. NEN models are constructed for basic research, including primary cell lines, organoids, and animal models.

Conditions

  • Neuroendocrine Neoplasm

Interventions

PROCEDURE

Biopsy, open or laparoscopic surgery

Collect NEN and PDAC biopsy or surgical fresh tissue to conduct single cell sequencing or model construction.

Sponsors & Collaborators

  • D1 Medical Technology (Shanghai) Co., Ltd, China

    collaborator INDUSTRY

  • Fudan University

    lead OTHER

Principal Investigators

  • Xianjun Yu, MD, PhD · Fudan University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-06
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927611 on ClinicalTrials.gov